We are live on ! Find out more
BIOL

Biolase, Inc.

Delisted

BIOL was delisted on the 18th of June, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.46M
PCM
2
Perkins Capital Management
Minnesota
$2M +$8.16K +5 +0.4%
BlackRock
3
BlackRock
New York
$1.93M +$1.63K +1 +0.1%
Millennium Management
4
Millennium Management
New York
$1.01M +$1.01M +618 +5,150%
Renaissance Technologies
5
Renaissance Technologies
New York
$936K -$11.4K -7 -1%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$846K +$73.5K +45 +9%
GCP
7
GSA Capital Partners
United Kingdom
$802K +$820K +502 New
EIM
8
Essex Investment Management
Massachusetts
$511K +$522K +320 New
Marshall Wace
9
Marshall Wace
United Kingdom
$481K +$491K +301 New
State Street
10
State Street
Massachusetts
$267K -$80K -49 -23%
Two Sigma Advisers
11
Two Sigma Advisers
New York
$248K +$219K +134 +638%
Northern Trust
12
Northern Trust
Illinois
$179K +$3.27K +2 +2%
VF
13
Virtu Financial
New York
$133K -$6.53K -4 -5%
Two Sigma Investments
14
Two Sigma Investments
New York
$123K +$53.9K +33 +75%
DA
15
DCM Advisors
New York
$62K
Citadel Advisors
16
Citadel Advisors
Florida
$56K +$44.1K +27 +338%
Charles Schwab
17
Charles Schwab
California
$38K
Morgan Stanley
18
Morgan Stanley
New York
$36K +$11.4K +7 +44%
OCM
19
Orion Capital Management
California
$32K
Commonwealth Equity Services
20
Commonwealth Equity Services
Massachusetts
$31K +$32.6K +20 New
AI
21
Atom Investors
Texas
$30K +$31K +19 New
CS
22
Credit Suisse
Switzerland
$29K +$29.4K +18 New
Jane Street
23
Jane Street
New York
$26K +$26.1K +16 New
CG
24
CFO4Life Group
Texas
$21K
MA
25
MONECO Advisors
Connecticut
$19K